Health knowledge and news provided by doctors.

''Brown Fat'' Cells Hold Clues for Possible Obesity Treatments

Armen Hareyan's picture

Scientists at Joslin Diabetes Center and Children's Hospital Boston have discovered a group of genes that govern the genesis of calorie-burning fat cells. This discovery may lead to new ways to treat obesity, which is now at epidemic levels.

Drs. Yu-Hua Tseng, and Atul J. Butte of Children's Hospital Boston and HMS, shared first authorship on the study, which appears in the June edition of the journal Nature Cell Biology.

In laboratory studies of mouse cells, the research team identified genes that govern how precursor cells give rise to mature brown fat cells. There are two main types of fat cells in the body -- white and brown. White fat cells are the ''conventional'' form of fat that we all recognize. They are designed to store energy for use in times of need. Chocked full of lipid droplets, these big cells accumulate under the skin and around internal organs.

By contrast, the main role of brown fat cells is to burn energy and generate heat. They contain small lipid droplets tucked between tiny energy factories called mitochondria. In mice, brown fat cells are found throughout the body and are present during the entire life cycle. In humans, they are principally found in the neck area of newborns, helping their tiny bodies generate heat. Brown fat cells largely disappear by adulthood, but their precursors still remain in the body, lodged in white-fat depots.

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

Because brown fat cells burn calories, the scientists theorized that finding ways to encourage the development of brown fat might be good for treating obesity. In previous research, the scientists were among the first to develop cell lines of precursor cells that give rise to brown fat cells. ''We used those cell lines to study how insulin affects the conversion of fat precursors, or preadipocytes, into mature brown adipocytes,'' said Dr. Tseng.

The researchers compared cell lines from normal ''wild-type'' mice to cell lines from mice that genetically lacked key components of the insulin-signaling network which are important to insulin's role in letting food nutrients enter the body's cells. If cells resist insulin, the body cannot get the energy it needs. This ''insulin resistance'' is the main culprit in the onset of in type 2 diabetes. Being overweight or obese has long been implicated with insulin resistance and type 2 diabetes and also raises the risk for heart disease, stroke and cancer.

The team studied ''knockout'' cell lines of brown preadipocytes that lacked insulin receptor substrates (IRS) numbered 1 through 4, which are the first steps in insulin signaling inside the cell. In cell lines lacking IRS1, the precursors failed to develop into mature brown fat cells. Importantly, when they added the gene for IRS1 back into the knockout cells, the precursors recovered most of their ability to differentiate into brown fat cells. Varying effects occurred with the knockout of genes for IRS2, IRS3 and IRS4. Using DNA chips to analyze these cells, a strong genetic pattern emerged that predicted the potential of precursors to differentiate into mature brown fat cells.

Of the 347 genes that were altered in the cells that could not form brown fat, one of the most over-expressed was for a protein called necdin. Until this study, necdin was associated largely with nerve tissue and Prader-Willi syndrome, a neurodevelopmental disorder in children characterized by mental retardation, feeding problems and obesity. The Joslin researchers discovered that reducing the level of necdin is essential for precursor cells to give rise to brown fat cells. They also found that a transcription factor called CREB is involved in this reduction. ''As we learn more about the genesis of brown fat cells and the genes governing them, we may be able to target those genes with drugs or other agents to create powerful tools to fight obesity,'' said Dr. C. Ronald Kahn, President of Joslin Diabetes Center, Professor of Medicine at Harvard Medical School and principal investigator of the study.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, nine members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 325-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: http://www.childrenshospital.org/research.